Page last updated: 2024-09-03

sch 42495 and Heart Failure

sch 42495 has been researched along with Heart Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balding, LC; Burrell, LM; Farina, NK; Johnston, CI1

Other Studies

2 other study(ies) available for sch 42495 and Heart Failure

ArticleYear
SCH 42495.
    Drugs in R&D, 1999, Volume: 1, Issue:4

    Topics: Drugs, Investigational; Endopeptidases; Heart Failure; Humans; Hypertension; Methionine; Prodrugs; Protease Inhibitors

1999
Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiovascular System; Disease Models, Animal; Female; Heart Failure; Hormones; Kidney; Methionine; Myocardial Infarction; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Water

2000